SCImago Journal & Country Rank

Ranking and Indexing

Index Copernicus Value (2017): 105.85
CNCSIS B+ (code 820) since 2007

International Databases:
SCOPUS since 2009
EBSCO Academic Search Complete since 2008
Index Copernicus Journals Master List since 2009
Directory of Open Access Journals (DOAJ) since 2008
Genamics JournalSeek since 18/2008

International Catalogues:
Oxford University's Library since 2003

Journal Info

Title: Studia Universitatis Vasile Goldis, Seria Stiintele Vietii (Life Sciences Series)
Abbreviated title: Studia Univ. VG, SSV
Publisher: "Vasile Goldis" University Press
Owner: Western University "Vasile Goldis" Arad, Romania
ISSN: 1584-2363
e-ISSN: 1842-7863
ISSN-L: 1584-2363

Who's Online

We have 58 guests online

Index Databases

Initial empiric antibiotic treatment in severe bacterial infections Print E-mail
Written by Papagheorghe R.   
Read full article
Article Title: Initial empiric antibiotic treatment in severe bacterial infections
Authors: Papagheorghe R.
Affiliation: Central laboratory, Hospital Coltea, Bucharest, Romania
Abstract: The progress of diagnosis means of infections, the improvement of surgical techniques and large spectre antibiotic availability resulted in an important reduction of the morbidity and mortality produced by severe bacterial infections (SBIs) in the last century. Nevertheless, this pathology remains a major challenge for surgeons, internists, infectious diseases and microbiology specialists. The adequacy of initial empiric antibiotic therapy is life-saving. Progressive bacterial resistance and its spread within institutions limit the antibiotic treatment options and the patients’ outcome. This phenomenon is more obvious in Gramnegative bacilli which are the main cause of SBIs in countries were the antibiotic treatment is based rather on general guidelines than on local susceptibility data. This presentation discusses criteria for choosing empiric antimicrobial therapy aiming to reduce the use of unnecessary anti -pseudomonas antibiotics and outlines available therapies for these infections.
Keywords: bacterial infections, anti-pseudomonas antibiotics, multidrug resistant organisms
*Correspondence: Raluca Papagheorghe, Central laboratory, Hospital Coltea, Bucharest, Romania, email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it